NE
NeoGenomics
NEO·NASDAQFort Myers FLFounded 20012,000 employees
Mid CapbiotechPublicOncology
Platform: Onc Dx Lab
Market Cap
$2.5B
All Drugs
3
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (NEO)
Loading NEO stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| NEO-5036 | NEO-5036 | Phase 1/2 | 1 | HER2 | PAHCLL | ||
| NEO-620 | NEO-620 | Phase 2/3 | 2 | IL-13 | NBAS | ||
| NEO-1781 | NEO-1781 | NDA/BLA | 1 | DLL3 | Heart FailureBladder Ca |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)